NOMAD Power Solutions, Inc.(NMAD)

Biotechnology · Boca Raton, FL

$4.21+0.19 (+4.76%)

Delayed quote: Oct 6, 2026, 11:35 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T15:37:44.211Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:37:44.211Z.

Quote observation: 2026-10-06T15:35:11.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -5,498,151
Quote market capitalization: 51,988,148
Total debt · period ending 2026-06-30: 1,101
Cash · period ending 2026-06-30: 12,670

FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NMAD EBITDA Yield Metrics

EBITDA YIELD

N/A

NMAD Competitors' EBITDA Yield

NMAD

NOMAD Power Solutions, Inc.

Current

Market Cap

$51.99M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs NMAD

Market Cap

$51.98M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs NMAD

Market Cap

$51.91M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs NMAD

Market Cap

$51.83M

EBITDA Yield

10.99%

TTM Avg

20.03%

3Y Avg

16.76%

5Y Avg

21.84%

DWTX

Dogwood Therapeutics, Inc.

vs NMAD

Market Cap

$51.45M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs NMAD

Market Cap

$51.39M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBOT

Microbot Medical Inc.

vs NMAD

Market Cap

$51.27M

EBITDA Yield

N/A

TTM Avg

0.89%

3Y Avg

5.54%

5Y Avg

4.70%

INMB

INmune Bio, Inc.

vs NMAD

Market Cap

$51.18M

EBITDA Yield

N/A

TTM Avg

3.11%

3Y Avg

2.71%

5Y Avg

2.71%

COCH

Envoy Medical, Inc.

vs NMAD

Market Cap

$51.03M

EBITDA Yield

N/A

TTM Avg

0.59%

3Y Avg

0.59%

5Y Avg

0.59%

IMA

ImageneBio Inc

vs NMAD

Market Cap

$53.69M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
NOMAD Power Solutions, Inc. (NMAD)	$51.99M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.98M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.91M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.83M	10.99%	20.03%	16.76%	21.84%
Dogwood Therapeutics, Inc. (DWTX)vs ›	$51.45M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$51.39M	N/A	N/A	N/A	N/A
Microbot Medical Inc. (MBOT)vs ›	$51.27M	N/A	0.89%	5.54%	4.70%
INmune Bio, Inc. (INMB)vs ›	$51.18M	N/A	3.11%	2.71%	2.71%
Envoy Medical, Inc. (COCH)vs ›	$51.03M	N/A	0.59%	0.59%	0.59%
ImageneBio Inc (IMA)vs ›	$53.69M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

NMAD EBITDA Yield Metrics

NMAD Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics